HAITHAM JIFI-BAHLOOL: Open Payments
NPI 1063447514 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,520 in 157 payments from 17 companies in 2025. Trend: 2023 $3,139 · 2024 $2,628 · 2025 $2,520
Food & beverage: $2,520
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $649 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $431 |
| ABBVIE INC. | 46 | $388 |
| Amgen Inc. | 12 | $263 |
| Lilly USA, LLC | 15 | $209 |
| Medtronic, Inc. | 18 | $158 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| SHIELD THERAPEUTICS INC | 3 | $53 |
| Dexcom, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
Products named: Ozempic, Kerendia, MOUNJARO, SYNCHROMEDII, QULIPTA, OTEZLA, KRYSTEXXA, Wegovy.
Industry payments across TX — which companies pay providers there.
